Supplementary Figure 1 from Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer

Authors :: Jennifer S. Carew
Allison Berger
Michael Thomas
Stephen Blakemore
Michael Milhollen
Sean A. Beausoleil
Anthony Possemato
Claudia M. Espitia
Peter G. Smith
Kevin R. Kelly
Steffan T. Nawrocki
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 1755K, Supplemental Figure 1: Effects of targeted p65 knockdown on cisplatin sensitivity.

Full Text Access

Tools